These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31873827)

  • 21. A single healthcare experience with Impella RP.
    Shekiladze N; Condado JF; Sandesara PB; Kim JH; Devireddy C; McDaniel M; Babaliaros V; Samady H; Kumar G; Jaber WA
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):E161-E167. PubMed ID: 32569445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.
    Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P
    Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis.
    den Uil CA; Akin S; Jewbali LS; Dos Reis Miranda D; Brugts JJ; Constantinescu AA; Kappetein AP; Caliskan K
    Eur J Cardiothorac Surg; 2017 Jul; 52(1):14-25. PubMed ID: 28472406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous biventricular Impella support in therapy-refractory cardiogenic shock.
    Chiu CY; Hättasch R; Praeger D; Knebel F; Stangl K; Ramirez ID; Dreger H
    Heart Lung; 2018; 47(3):250-252. PubMed ID: 29628145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early Escalation of Mechanical Circulatory Support Stabilizes and Potentially Rescues Patients in Refractory Cardiogenic Shock.
    Tongers J; Sieweke JT; Kühn C; Napp LC; Flierl U; Röntgen P; Schmitto JD; Sedding DG; Haverich A; Bauersachs J; Schäfer A
    Circ Heart Fail; 2020 Mar; 13(3):e005853. PubMed ID: 32164431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry.
    Annamalai SK; Esposito ML; Jorde L; Schreiber T; A Hall S; O'Neill WW; Kapur NK
    J Card Fail; 2018 Oct; 24(10):706-710. PubMed ID: 30244180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When Harry Met Sally: Single-Session INARI FlowTriever and Impella RP.
    Agarwal S; Saum J; Chanamalou S; Cole W; Patel SM
    J Cardiol Cases; 2021 Feb; 23(2):57-60. PubMed ID: 33520023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience.
    Engström AE; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; de Jong M; Lagrand WK; van der Sloot JA; Tijssen JG; de Winter RJ; de Mol BA; Piek JJ; Henriques JP
    Crit Care Med; 2011 Sep; 39(9):2072-9. PubMed ID: 21602670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facilitated cardiac recovery in fulminant myocarditis: pediatric use of the Impella LP 5.0 pump.
    Andrade JG; Al-Saloos H; Jeewa A; Sandor GG; Cheung A
    J Heart Lung Transplant; 2010 Jan; 29(1):96-7. PubMed ID: 19782584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of Impella 5.0 in Cardiogenic Shock: A Systematic Review and Meta-analysis.
    Batsides G; Massaro J; Cheung A; Soltesz E; Ramzy D; Anderson MB
    Innovations (Phila); 2018; 13(4):254-260. PubMed ID: 30142110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The right axillary artery approach for the Impella Recover LP 5.0 microaxial pump.
    Sassard T; Scalabre A; Bonnefoy E; Sanchez I; Farhat F; Jegaden O
    Ann Thorac Surg; 2008 Apr; 85(4):1468-70. PubMed ID: 18355563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secular Trend in the Use and Implementation of Impella in High-Risk Percutaneous Coronary Intervention and Cardiogenic Shock: A Real-World Experience.
    Hritani AW; Wani AS; Olet S; Lauterbach CJ; Allaqaband SQ; Bajwa T; Jan MF
    J Invasive Cardiol; 2019 Sep; 31(9):E265-E270. PubMed ID: 31478893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview of Impella and mechanical devices in cardiogenic shock.
    Chera HH; Nagar M; Chang NL; Morales-Mangual C; Dous G; Marmur JD; Ihsan M; Madaj P; Rosen Y
    Expert Rev Med Devices; 2018 Apr; 15(4):293-299. PubMed ID: 29600725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
    Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
    J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction.
    Casassus F; Corre J; Leroux L; Chevalereau P; Fresselinat A; Seguy B; Calderon J; Coste P; Ouattara A; Roques X; Barandon L
    J Interv Cardiol; 2015 Feb; 28(1):41-50. PubMed ID: 25689547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of heart failure due to acute transplant rejection with the Impella LP 5.0.
    Samoukovic G; Al-Atassi T; Rosu C; Giannetti N; Cecere R
    Ann Thorac Surg; 2009 Jul; 88(1):271-3. PubMed ID: 19559242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support.
    Lü F; Eckman PM; Liao KK; Apostolidou I; John R; Chen T; Das GS; Francis GS; Lei H; Trohman RG; Benditt DG
    Int J Cardiol; 2013 Oct; 168(4):3859-65. PubMed ID: 23863501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impella RP Versus Pharmacologic Vasoactive Treatment in Profound Cardiogenic Shock due to Right Ventricular Failure.
    Josiassen J; Helgestad OKL; Udesen NLJ; Banke A; Frederiksen PH; Schmidt H; Jensen LO; Hassager C; Møller JE; Ravn HB
    J Cardiovasc Transl Res; 2021 Dec; 14(6):1021-1029. PubMed ID: 33977379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience.
    Engström AE; Granfeldt H; Seybold-Epting W; Dahm M; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; Koch KT; De Jong M; Lagrand WK; Van Der Sloot JA; Tijssen JG; De Winter RJ; De Mol BA; Piek JJ; Henriques JP
    Minerva Cardioangiol; 2013 Oct; 61(5):539-46. PubMed ID: 24096248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro comparison of support capabilities of intra-aortic balloon pump and Impella 2.5 left percutaneous.
    Schampaert S; van't Veer M; van de Vosse FN; Pijls NH; de Mol BA; Rutten MC
    Artif Organs; 2011 Sep; 35(9):893-901. PubMed ID: 21819436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.